US Patent 9206216 Modified nucleotides methods and kits
Patent 9206216 was granted and assigned to Pierce Biotechnology on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+263 characters)
Article
Patent abstract
Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09206216 Modified nucleotides methods and kits US Patent 9206216 Modified nucleotides methods and kits
Infobox
Patent Number
092062160
Patent Number
92062160
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
092062160
Date of Patent
December 8, 2015
0Patent Application Number
134829270
Date Filed
May 29, 2012
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09206216 Modified nucleotides methods and kits
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09206216
Date of patent
December 8, 2015
Patent application number
13482927
Date Filed
May 29, 2012
Patent primary examiner
Find more entities like US Patent 9206216 Modified nucleotides methods and kits
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.